Drones Are Learning to Deliver Organs. The FAA Is Still Learning to Let Them.

Drones Are Learning to Deliver Organs. The FAA Is Still Learning to Let Them.

The partnership that UNOS and NASA signed last week in Richmond, Virginia was not a product launch. It was an admission.

"This partnership shows what's possible when innovation and mission-driven health care come together," Mark Johnson, interim CEO of the United Network for Organ Sharing, said at the signing ceremony. That sounds like a press release. But read it again, and what it actually says is: the existing system was not enough.

UNOS, which runs the Organ Procurement and Transplantation Network under federal contract, has a logistics problem it cannot algorithm its way out of. Organs expire. Not because surgeons could not save them — because traffic held up a courier, or a commercial flight missed its connection, or the helicopter was grounded by weather. Approximately 3,500 organs a year are discarded due to transportation failures, according to ParaFlight, a medical aviation logistics company. Hearts and lungs have windows of four to six hours. Livers hold for twelve to twenty-four. Every minute of that window spent on a tarmac or a highway is a minute the patient on the other end cannot get back.

So UNOS called NASA.

The agreement, signed April 21 at UNOS headquarters, kicks off a study led by NASA's Langley Research Center in Hampton, Virginia. Phase one is not about flying organs — it is about measuring what happens to organs when they fly. Researchers will instrument drones to track temperature, vibration, and altitude effects during flights carrying research or animal organs. NASA will model first-mile and last-mile routes: the short urban and suburban hops between harvest site and transplant center, or airport and hospital, where ground traffic makes the difference between a viable organ and a discarded one.

"We couldn't be more pleased to be a part of this," said John Koelling, director of aeronautics research at NASA Langley, at the ceremony. "Doing something in my backyard that could change the world — how cool is that? That's almost as cool as stepping foot on the moon."

Koelling's quote is the one other outlets will lead with. It is a good quote. But the more honest lede is the one Johnson did not say out loud: we need NASA to solve a problem that should not exist.

The technical barriers are real but not the story's core risk. Seven years ago, the University of Maryland flew a donor kidney 2.8 miles across Baltimore on a custom-built eight-rotor UAS and transplanted it into a 44-year-old woman who had spent eight years on dialysis, according to ScienceDaily. The flight worked. The patient recovered. The technology existed. What did not exist was the regulatory scaffolding, the operational scale, or the institutional confidence to treat it as infrastructure rather than a proof-of-concept.

That is what has changed — and what has not. The FAA published a report in May 2025 as part of the 2024 FAA Reauthorization Act, laying out roughly twenty recommendations for transporting organs in commercial aircraft cabins, according to ScubaTx, a medical logistics analysis firm. That work addresses the long-haul piece of the problem: getting organs onto passenger planes with proper handling protocols. But the first-mile and last-mile problem — the specific challenge that drones are best positioned to solve — still lacks a regulatory pathway for beyond-visual-line-of-sight flight over populated urban areas. UNOS and NASA are building the science case. The FAA still has to build the rule.

Future phases of the partnership are expected to address scalability, longer flight testing, and the regulatory framework for expanded medical drone operations. That is the critical line in the press release, because it names what phase one conspicuously does not include: a timeline, a flight testing schedule, or a procurement commitment.

This is where the story earns its headline. Drones have been promising to change logistics for a decade. Amazon has been writing about Prime Air since 2013. Zipline has been delivering blood and vaccines in Rwanda and Ghana since 2016. The drone industry has regulatory exemptions, pilot programs, and press releases. What it has not had is a federally-backed, federally-engineered proof of concept for the use case that makes the most intuitive sense: delivering a heart before the window closes.

If NASA validates the science, the downstream effect is not just organ transport. The instrumentation standards, flight corridor models, and regulatory recommendations produced by this partnership become the template for a broader medical drone infrastructure — blood supplies, emergency reagents, surgical tools for remote hospitals. The drone industry's long-awaited breakthrough may not come from a warehouse in Ohio or a test range in Nevada. It may come from a transplant corridor in Virginia.

Whether this partnership produces a working system before the regulatory questions resolve is the real question. The honest answer is: nobody knows. What is clear is that the problem is no longer theoretical, and the partners working on it are no longer startups.

The organ will be on the drone. The question is whether the rulebook will be ready when it arrives.